Co-insurance rate of 58%, 28% or 0%, depending on drug category. A co-payment of EUR 3.00 (USD 3.19) per prescription applies when the medicine is fully reimbursed. Patient cost-sharing is capped to EUR 700.92 (USD 746.29). Any difference between retail price and reference price for products subject to reference pricing is paid by the patient. Changes to co-insurance rates and spending cap were expected in 2013.